Literature DB >> 22486301

Long-term comparison of video-assisted thoracic sympathectomy and clinical observation for the treatment of palmar hyperhidrosis in children younger than 14.

Samantha Neves1, Patricia C Uchoa, Nelson Wolosker, Marco A Munia, Paulo Kauffman, Jose Ribas M de Campos, Pedro Puech-Leão.   

Abstract

The results of video-assisted thoracic sympathectomy (VATS)in children are unknown. To investigate the improvement in quality of life (QOL) of a group of 45 children who did and did not undergo VATS for the treatment of palmar hyperhidrosis (PH) 4 years after the initial evaluation. Forty-five children with PH were initially evaluated. Children were divided into two groups: 30 in the VATS group and 15 in the control group. We studied the evolution of PH, negative effect of hyperhidrosis on the QOL before the treatment, and improvement in QOL after treatment. Twenty-five patients (83.4%) in the VATS group experienced great improvement in PH, and five (16.6%) experienced partial improvement; 12 (80.0%) children from the control group had some type of improvement, and three (20.0%) had partial improvement. Two (13.3%) children in the control group and 23 (76.7%) in the VATS group had great improvement in QOL. For children with PH and poor QOL, VATS is better than no treatment. It produces better results with regard to sweating and greater improvement in QOL.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22486301     DOI: 10.1111/j.1525-1470.2012.01751.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  2 in total

1.  Over a decade of single-center experience with thoracoscopic sympathicolysis for primary palmar hyperhidrosis: a case series.

Authors:  Adam Mol; Oliver J Muensterer
Journal:  Surg Endosc       Date:  2020-07-08       Impact factor: 4.584

2.  Epidemiologic analysis of prevalence of the hyperhidrosis.

Authors:  Fernanda Alvarenga Estevan; Marina Borri Wolosker; Nelson Wolosker; Pedro Puech-Leão
Journal:  An Bras Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.